Jia (Jenny) Liu, Translational Lead of Early Phase Drug Development at The Kinghorn Cancer Centre, shared a post on LinkedIn:
“Wonderful talks by Ecaterina Dumbrava at MOGA25 annual meeting on novel therapies and combinations emerging in drug development, including TP53, KRASi (drugging the undruggable), importance of precision oncology decision support tools, need for collaboration to reduce cost/inefficiency in drug development, and multidisciplinary brain cancer clinic.
Thanks for coming down to Australia!
And on the topic of the wave of ADCs… need to learn how to surf!”
More posts featuring Jia (Jenny) Liu.
